
AN2 Therapeutics, Inc.
NASDAQ:ANTX
1.22 (USD) • At close May 8, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|---|
Operating Activities: | ||||||
Net Income
| -51.321 | -64.732 | -40.956 | -21.543 | -13.603 | -5.635 |
Depreciation & Amortization
| 0 | 0 | -0.692 | 0 | 0 | 0 |
Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 |
Stock Based Compensation
| 8.338 | 8.412 | 4.391 | 0.974 | 0.04 | 0 |
Change In Working Capital
| -2.995 | 5.834 | 3.718 | 0.032 | 1.224 | -0.01 |
Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 |
Inventory
| 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Payables
| 0.641 | 0.553 | 2.497 | 0.417 | 0.081 | -0.016 |
Other Working Capital
| -3.636 | 5.281 | 1.221 | -0.385 | 1.143 | 0.006 |
Other Non Cash Items
| -3.279 | -2.802 | 0.077 | 0.053 | 6.975 | 3.175 |
Operating Cash Flow
| -49.257 | -53.288 | -33.462 | -20.484 | -5.364 | -2.486 |
Investing Activities: | ||||||
Investments In Property Plant And Equipment
| 0 | 0 | 0 | 0 | 0 | 0 |
Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 |
Purchases Of Investments
| -46.751 | -132.178 | -93.836 | -77.274 | 0 | 0 |
Sales Maturities Of Investments
| 101.34 | 88.9 | 72.065 | 27.25 | 0 | 0 |
Other Investing Activites
| 0 | 0 | -0.022 | -0.05 | 0 | 0 |
Investing Cash Flow
| 54.589 | -43.278 | -21.771 | -50.024 | 0 | 0 |
Financing Activities: | ||||||
Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock Issued
| 0 | 84.529 | 70.366 | 78.535 | 3.836 | 8.084 |
Common Stock Repurchased
| 0 | 0 | -0.011 | 0 | 0 | 0 |
Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing Activities
| 0.372 | 0.465 | -0.011 | 78.535 | 3.836 | 48.504 |
Financing Cash Flow
| 0.372 | 84.994 | 70.355 | 78.535 | 3.836 | 8.084 |
Other Information: | ||||||
Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 |
Net Change In Cash
| 5.704 | -11.572 | 15.122 | 8.027 | -1.528 | 5.598 |
Cash At End Of Period
| 21.351 | 15.647 | 27.219 | 12.097 | 4.07 | 5.598 |